Clostridium Difficile (C. Difficile) Completed Phase 4 Trials for Fidaxomicin (DB08874)

Back to Clostridium Difficile (C. Difficile)

Also known as: C-Difficile / Difficile / C. Difficile

IndicationStatusPhase
DBCOND0120840 (Clostridium Difficile (C. Difficile))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02057198
Impact of Oral Antibiotic Treatment on C. DifficileTreatment
NCT02667418
Optimal Treatment for Recurrent Clostridium DifficileTreatment